Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial

被引:5
作者
Farmer, Andrew [1 ]
Jones, Louise [1 ]
Newhouse, Nikki [1 ]
Kenning, Cassandra [2 ]
Williams, Nicola [1 ]
Chi, Yuan [3 ]
Bartlett, Y. Kiera [4 ]
Plumpton, Catrin [5 ]
McSharry, Jenny [6 ]
Cholerton, Rachel [4 ]
Holmes, Emily [5 ]
Robinson, Stephanie [1 ]
Allen, Julie [1 ]
Gudgin, Bernard [1 ]
Velardo, Carmelo [3 ,7 ]
Rutter, Heather [1 ,8 ]
Horne, Rob [9 ]
Tarassenko, Lionel [3 ]
Williams, Veronika [10 ]
Locock, Louise [11 ]
Rea, Rustam [12 ,13 ]
Yu, Ly-Mee [1 ]
Hughes, Dyfrig [5 ]
Bower, Peter [2 ]
French, David [4 ]
机构
[1] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Gibson Bldg,Radcliffe Observ Quarter, Oxford OX2 6GG, England
[2] Univ Manchester, Ctr Primary Care & Hlth Serv Res, Manchester, Lancs, England
[3] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England
[4] Univ Manchester, Manchester Ctr Hlth Psychol, Manchester, Lancs, England
[5] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales
[6] Natl Univ Ireland Galway, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland
[7] Sensyne Hlth Plc, Oxford, England
[8] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Oxford, England
[9] UCL, Ctr Behav Med, London, England
[10] Nipissing Univ, Sch Nursing, North Bay, ON, Canada
[11] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland
[12] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[13] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England
基金
美国国家卫生研究院;
关键词
diabetes; SMS text messages; cardiovascular risk prevention; medication adherence; digital health; randomized controlled trial; CORONARY-HEART-DISEASE; ADHERENCE; MODEL; INTERVENTIONS; MEDICATIONS; MELLITUS;
D O I
10.2196/32918
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Type 2 diabetes is a common lifelong condition that affects over 400 million people worldwide. The use of effective medications and active self-management can reduce the risk of serious complications. However, people often have concerns when starting new medications and face difficulties in taking their medications regularly. Support provided by brief messages delivered through mobile phone-based SMS text messages can be effective in some long-term conditions. We have identified promising behavior change techniques (BCTs) to promote medication adherence in this population via a systematic review and developed SMS text messages that target these BCTs. Feasibility work has shown that these messages have fidelity to intended BCTs, are acceptable to patients, and are successful in changing the intended determinants of medication adherence. We now plan to test this intervention on a larger scale in a clinical trial. Objective: The aim of this trial is to determine the effectiveness and cost-effectiveness of this intervention for reducing cardiovascular risk in people with type 2 diabetes by comparing it with usual care. Methods: The trial will be a 12-month, multicenter, individually randomized controlled trial in primary care and will recruit adults (aged >= 35 years) with type 2 diabetes in England. Consenting participants will be randomized to receive short SMS text messages intended to affect a change in medication adherence 3 to 4 times per week in addition to usual care. The aim is to test the effectiveness and cost-effectiveness of the intervention when it is added to usual care. The primary clinical outcome will be a composite cardiovascular risk measure. Data including patient-reported measures will be collected at baseline, at 13 and 26 weeks, and at the end of the 12-month follow-up period. With 958 participants (479 in each group), the trial is powered at 92.5% to detect a 4-percentage point difference in cardiovascular risk. The analysis will follow a prespecified plan. A nested quantitative and qualitative process analysis will be used to examine the putative mechanisms of behavior change and wider contextual influences. A health economic analysis will be used to assess the cost-effectiveness of the intervention. Results: The trial has completed the recruitment phase and is in the follow-up phase. The publication of results is anticipated in 2024. Conclusions: This trial will provide evidence regarding the effectiveness and cost-effectiveness of this intervention for people with type 2 diabetes.
引用
收藏
页数:12
相关论文
共 42 条
[1]  
[Anonymous], 1995, Diabetes, V44, P1249
[2]  
[Anonymous], 2016, GLOBAL REPORT DIABET
[3]  
[Anonymous], 2015, PATIENT ADHERENCE ME
[4]   Effects of Using a Text Message Intervention on Psychological Constructs and the Association Between Changes to Psychological Constructs and Medication Adherence in People With Type 2 Diabetes: Results From a Randomized Controlled Feasibility Study [J].
Bartlett, Yvonne Kiera ;
Farmer, Andrew ;
Newhouse, Nikki ;
Miles, Lisa ;
Kenning, Cassandra ;
French, David P. .
JMIR FORMATIVE RESEARCH, 2022, 6 (04)
[5]   Use of Brief Messages Based on Behavior Change Techniques to Encourage Medication Adherence in People With Type 2 Diabetes: Developmental Studies [J].
Bartlett, Yvonne Kiera ;
Farmer, Andrew ;
Rea, Rustam ;
French, David P. .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (05)
[6]   What do people with type 2 diabetes want from a brief messaging system to support medication adherence? [J].
Bartlett, Yvonne Kiera ;
Newhouse, Nikki ;
Long, Hannah A. ;
Farmer, Andrew J. ;
French, David P. .
PATIENT PREFERENCE AND ADHERENCE, 2019, 13 :1629-1640
[7]   Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]) A Single-Blind, Randomized Trial [J].
Bobrow, Kirsten ;
Farmer, Andrew J. ;
Springer, David ;
Shanyinde, Milensu ;
Yu, Ly-Mee ;
Brennan, Thomas ;
Rayner, Brian ;
Namane, Mosedi ;
Steyn, Krisela ;
Tarassenko, Lionel ;
Levitt, Naomi .
CIRCULATION, 2016, 133 (06) :592-600
[8]   Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 [J].
Bommer, Christian ;
Sagalova, Vera ;
Heesemann, Esther ;
Manne-Goehler, Jennifer ;
Atun, Rifat ;
Baernighausen, Till ;
Davies, Justine ;
Vollmer, Sebastian .
DIABETES CARE, 2018, 41 (05) :963-970
[9]  
Braun V., 2006, Qual Res Psychol, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, DOI 10.1007/978-981-10-5251-4103]
[10]   SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials [J].
Chan, An-Wen ;
Tetzlaff, Jennifer M. ;
Altman, Douglas G. ;
Laupacis, Andreas ;
Gotzsche, Peter C. ;
Krleza-Jeric, Karmela ;
Hrobjartsson, Asbjorn ;
Mann, Howard ;
Dickersin, Kay ;
Berlin, Jesse A. ;
Dore, Caroline J. ;
Parulekar, Wendy R. ;
Summerskill, William S. M. ;
Groves, Trish ;
Schulz, Kenneth F. ;
Sox, Harold C. ;
Rockhold, Frank W. ;
Rennie, Drummond ;
Moher, David .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) :200-+